Fellowship · Jackson, MS
Sponsored by University of Mississippi School of Medicine
Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated MGMT promoter: An international randomized phase III trial.
Neuro-oncology · 2023 · 466 citations · Ashley Sumrall
Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoter.
Neuro-oncology · 2022 · 470 citations · Ashley Sumrall
Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma.
The New England journal of medicine · 2022 · 422 citations · Carter Milner
Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways.
Cancer discovery · 2023 · 146 citations · Ashley Sumrall
ONC201 (Dordaviprone) in Recurrent H3 K27M-Mutant Diffuse Midline Glioma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024 · 95 citations · Ashley Sumrall
Multiyear Factor VIII Expression after AAV Gene Transfer for Hemophilia A.
The New England journal of medicine · 2021 · 210 citations · Spencer Sullivan
Optimization of therapeutic antibodies for reduced self-association and non-specific binding via interpretable machine learning.
Nature biomedical engineering · 2024 · 40 citations · Stephanie Elkins
Telehealth in Oncology: ASCO Standards and Practice Recommendations.
JCO oncology practice · 2021 · 126 citations · Ashley Sumrall